Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Eszopiclone.

Client Email

Product

Eszopiclone
CAS 43200-81-3
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Eszopiclone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 20 USDMF, 3 JDMF, 8 EU WC, 10 NDC API, 17 Listed Suppliers, $ API Reference Price

35 API Suppliers
20 USDMF
3 JDMF
8 EU WC
10 NDC API
17 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

62 FDF Dossiers, 45 FDA Orange Book, 3 Europe, 3 Canada, 11 Listed Dossiers

62 FDF Dossiers
45 FDA Orange Book
3 Europe
3 Canada
11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 3MG

TABLET;ORAL - 1MG
TABLET;ORAL - 2MG
TABLET;ORAL - 3MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 4 DKSH, 2 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 35 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 34 Direct Compression, 27 Controlled & Modified Release, 22 Solubilizers, 21 Disintegrants & Superdisintegrants, 21 Thickeners and Stabilizers, 20 Granulation, 16 Co-Processed Excipients, 14 Film Formers & Plasticizers, 13 Topical, 13 Lubricants & Glidants, 12 Parenteral, 7 Taste Masking, 7 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

70 Fillers, Diluents & Binders
45 Coating Systems & Additives
34 Direct Compression
27 Controlled & Modified Release
22 Solubilizers
21 Disintegrants & Superdisintegrants
21 Thickeners and Stabilizers
20 Granulation
16 Co-Processed Excipients
14 Film Formers & Plasticizers
13 Topical
13 Lubricants & Glidants
12 Parenteral
7 Taste Masking
7 Emulsifying Agents
6 Chewable & Orodispersible Aids
5 Empty Capsules
5 API Stability Enhancers
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules
3 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 15 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 9 Finished Drug Prices, 7 Annual Reports

2 US Medicaid Prescriptions
9 Finished Drug Prices
7 Annual Reports

MARKET PLACE

4 APIs

4 APIs

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 2 Others

2 USP
2 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,365 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Sunovion Pharmaceuticals Canada Inc.

filter Patent Reset all filters

3 All

01 32750059

filter Product Reset all filters

3 All

01 3ESZOPICLONE

filter Dosage Reset all filters

3 All

01 3TABLET

filter Exp Date Reset all filters

3 All

01 32030-01-28

Farmak Eszopiclone

Product Main Page

01

Sunovion Pharmaceuticals Can...

Eszopiclone

AAPS 2024

Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Eszopiclone

Brand Name : LUNESTA

Patent Number : 2750059

Filing Date : 2010-01-28

Strength per Unit : 1 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Sunovion Pharmaceuticals Can...

Eszopiclone

AAPS 2024

Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Eszopiclone

Brand Name : LUNESTA

Patent Number : 2750059

Filing Date : 2010-01-28

Strength per Unit : 2 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Sunovion Pharmaceuticals Can...

Eszopiclone

AAPS 2024

Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Eszopiclone

Brand Name : LUNESTA

Patent Number : 2750059

Filing Date : 2010-01-28

Strength per Unit : 3 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-28

Date Granted : 2014-11-18

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?